Mode
Text Size
Log in / Sign up

Oncology

592 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case Report Describes Non-Secretory Multiple Myeloma With Eosinophilia in a 56-Year-Old Man
Oncology Sys. Review
Case Report Describes Non-Secretory Multiple Myeloma With Eosinophilia in a 56-Year-Old Man Back Pain and High White Cells: A Hidden Cancer Case
This case report details a 56-year-old man presenting with multiple myeloma and eosinophilia. Diagnosis of non-secretory multiple myeloma wa…
This case shows how a rare blood cancer can hide behind common symptoms, making early diagnosis difficult but crucial.
Review highlights diagnostic challenges in testicular mucinous cystic neoplasm management.
Oncology Sys. Review
Review highlights diagnostic challenges in testicular mucinous cystic neoplasm management. A rare testicular cyst in an older man turned out to be a sign of hidden abdominal cancer.
This case report and literature review describes a 78-year-old man who underwent scrotal exploration and right radical orchiectomy for a tes…
A rare testicular cyst in an older man turned out to be a sign of hidden abdominal cancer, highlighting the need for careful follow-up.
CT imaging models differentiate benign from malignant orbital tumors in retrospective cohort of 145 patients.
Oncology Cohort
CT imaging models differentiate benign from malignant orbital tumors in retrospective cohort of 145 patients. New Eye Scan AI Could Stop Unnecessary Surgeries
This retrospective cohort study evaluated CT imaging models in 145 patients with orbital tumors diagnosed between December 2014 and March 20…
A new computer tool helps doctors tell harmless eye growths from cancer using standard scans.
Multi-task learning model for gastrointestinal cancer histopathology demonstrates high classification and segmentation performance in preclinical validation.
Oncology Cohort
Multi-task learning model for gastrointestinal cancer histopathology demonstrates high classification and segmentation performance in preclinical validation. New AI tool shows promise for analyzing gastrointestinal cancer tissue samples.
This preclinical validation system evaluated a multi-task learning model using approximately 99,000 histopathological patches from gastroint…
A new computer model analyzed nearly 100,000 cancer images and performed better than existing tools at identifying and measuring tumor featu…
High prevalence and multidrug resistance of gram-negative bloodstream infections in children with acute myeloid leukemia
Oncology Cohort
High prevalence and multidrug resistance of gram-negative bloodstream infections in children with acute myeloid leukemia Antibiotic-Resistant Infections Are Hitting Kids With Leukemia Harder Than We Thought
This retrospective cohort study evaluated 90 children with acute myeloid leukemia admitted for induction chemotherapy at a single center. Th…
This research shows that drug-resistant infections are a major, often deadly threat to children undergoing leukemia treatment, highlighting …
High NSUN3 expression linked to poor survival in oral squamous cell carcinoma
Oncology Cohort
High NSUN3 expression linked to poor survival in oral squamous cell carcinoma High NSUN3 protein makes oral cancer spread faster
This cohort study of 60 oral squamous cell carcinoma patients found that upregulated NSUN3 expression is an independent risk factor for poor…
Imagine waking up with a sore in your mouth that won't heal.
ERS-related DNA methylation profiles stratify glioblastoma patients into four subtypes with 92.4% prediction accuracy.
Oncology Cohort
ERS-related DNA methylation profiles stratify glioblastoma patients into four subtypes with 92.4% prediction accuracy. New AI Tool Could Help Doctors Choose Better Brain Tumor Treatments
This cohort analysis of a TCGA glioblastoma population integrated ERS-related DNA methylation profiles with non-negative matrix factorizatio…
Scientists used AI to find hidden patterns in brain tumors that could lead to better treatment plans.
Multimodal MRI quantitative parameters associated with prognosis in non-metastatic primary osteosarcoma patients in retrospective cohort
Oncology Cohort
Multimodal MRI quantitative parameters associated with prognosis in non-metastatic primary osteosarcoma patients in retrospective cohort New MRI Scan Predicts Who Will Heal Faster From Bone Cancer
This retrospective cohort study evaluated 169 good prognosis and 52 poor prognosis patients with non-metastatic primary osteosarcoma treated…
Doctors now have a better way to guess how a patient will do before treatment even starts.
Review analyzes genomic sequencing mutation abundances in U.S. cancer patients versus typical pan-cancer analysis.
Oncology
Review analyzes genomic sequencing mutation abundances in U.S. cancer patients versus typical pan-cancer analysis. Most Common Cancer Mutation Found in U.S. Patients
This data analysis review examines genomic sequencing efforts within the U.S. cancer patient population. It reports specific mutation abunda…
Imagine walking into a doctor's office for a routine checkup.
FDA Approves Ontruzant (trastuzumab-dttb) for HER2-Overexpressing Breast and Gastric Cancers
Oncology FDA Approval
FDA Approves Ontruzant (trastuzumab-dttb) for HER2-Overexpressing Breast and Gastric Cancers FDA approves new cancer drug called Ontruzant for certain breast and stomach cancers
Ontruzant (trastuzumab-dttb) is approved for HER2-overexpressing breast cancer and metastatic gastric or gastroesophageal junction adenocarc…
The FDA has approved a new drug called Ontruzant for treating certain breast and stomach cancers. It works for cancers that have too much of…
Envafolimab plus lenvatinib and paclitaxel shows activity in advanced gastric cancer after first-line progression.
Oncology Phase II
Envafolimab plus lenvatinib and paclitaxel shows activity in advanced gastric cancer after first-line progression. New Drug Combo Gives Hope for Late-Stage Stomach Cancer
This phase II, single-center, open-label trial evaluated envafolimab combined with lenvatinib and albumin-bound paclitaxel in 30 patients wi…
Imagine a patient who has already tried every standard treatment available.
Comprehensive review compares ICI-based regimens and ICI-TKI combinations against sunitinib in metastatic renal cell carcinoma.
Oncology Sys. Review
Comprehensive review compares ICI-based regimens and ICI-TKI combinations against sunitinib in metastatic renal cell carcinoma. Kidney Cancer Treatment Just Took a Sharp Turn
This comprehensive review evaluates contemporary immune checkpoint inhibitor (ICI)-based regimens and ICI-tyrosine kinase inhibitor (TKI) co…
New kidney cancer treatments help patients live longer with fewer side effects than older drugs, giving more people a fighting chance agains…